Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Connective and Soft Tissue

Explore clinical trials studying Neoplasms, Connective and Soft Tissue. Study availability and eligibility vary by location and protocol.

2,726 public trials 585 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Connective and Soft Tissue trial results

Active, Not Recruiting

Osteosarcoma Maintenance Therapy With OST31-164

NCT04974008

Conditions
Bone Cancer, Bone Diseases, Bone Neoplasms, +9 more
Locations
  • Kaiser Permanente Downey Medical Center Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Rady Children's Hospital San Diego, California, United States
  • Children's Hospital of Colorado Aurora, Colorado, United States
View all 21 locations
View Trial Details
Active, Not Recruiting

Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors

NCT03709680

Conditions
Bone Diseases, Bone Neoplasms, Brain Diseases, +35 more
Locations
  • University of Alabama at Birmingham/Children's of Alabama Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • MemorialCare Health System - Long Beach Medical Center Long Beach, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
View all 101 locations
View Trial Details
Active, Not Recruiting

Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS

NCT05688280

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +36 more
Locations
  • Miami Cardiac & Vascular Institute Coral Gables, Florida, United States
  • University of Louisville Physicians, PSC Louisville, Kentucky, United States
  • Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • Institut Bergonie Bordeaux, France
View all 16 locations
View Trial Details
Active, Not Recruiting

Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial

NCT03150914

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • Stanford University Palo Alto, California, United States
  • National Jewish Hospital Denver, Colorado, United States
  • Emory University Atlanta, Georgia, United States
  • Loyola University Chicago, Illinois, United States
View Trial Details
Active, Not Recruiting

Surveillance AFter Extremity Tumor surgerY

NCT03944798

Conditions
Lung Metastases, Neoplasms, Neoplasms by Histologic Type, +3 more
Locations
  • University of California Davis Medical Center Sacramento, California, United States
  • Hartford HealthCare Hartford, Connecticut, United States
  • University of Florida Health Shands Hospital Gainesville, Florida, United States
  • UChicago Medicine Chicago, Illinois, United States
View all 35 locations
View Trial Details
Active, Not Recruiting

Pazopanib Vs. Pazopanib Plus Gemcitabine

NCT02203760

Conditions
Carcinosarcoma, Disease Attributes, Leiomyosarcoma, +10 more
Locations
  • Universitätsklinikum Bonn Bonn, Germany
  • Helios Klinikum Berlin-Buch, Klinik für Onkologie und Paliativmedizin Berlin, Germany
  • Universitätsmedizin Greifswald Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe Greifswald, Germany
  • Helios Klinikum Bad Saarow, Hämatologie, Onkologie und Palliativmedizin, Sarkomzentrum Bad Saarow, Germany
View Trial Details
Active, Not Recruiting

RNASARC - Molecular Screening Program of Soft Tissue Sarcomas With Complex Genomic Profile to Detect NTRK1/2/3, ROS1 or ALK Gene Fusions.

NCT03375437

Conditions
Advanced Cancer, Metastatic Cancer, Neoplasm Metastasis, +8 more
Locations
  • Centre Jean Perrin Clermont-Ferrand, France
  • Centre Georges-Francois Leclerc Dijon, France
  • Centre Oscar Lambret Lille, France
  • CHU de Limoges Hôpital Dupuytren Limoges, France
View Trial Details

Related conditions